These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3678474)

  • 1. Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia.
    Parmeggiani L; Ferrant A; Rodhain J; Michaux JL; Sokal G
    Eur J Haematol; 1987 Sep; 39(3):228-32. PubMed ID: 3678474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Splenic extramedullary hematopoiesis in myelofibrosis. Pathogenetic considerations apropos of a personally studied case].
    Piaserico PL; Piaserico GP
    Minerva Med; 1983 Oct; 74(39):2313-8. PubMed ID: 6657100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasia.
    Barosi G; Liberato LN; Costa A; Buratti A; Di Dio F; Salvatore S; Ascari E
    Eur J Haematol Suppl; 1990; 52():12-4. PubMed ID: 2279538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia.
    Tefferi A; Elliot MA; Yoon SY; Li CY; Mesa RA; Call TG; Dispenzieri A
    Blood; 2001 Mar; 97(6):1896. PubMed ID: 11263440
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly.
    Wolf BC; Neiman RS
    Blood; 1985 Apr; 65(4):803-9. PubMed ID: 3978228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.
    Barosi G; Liberato LN; Costa A; Ascari E
    Blut; 1989 Jun; 58(6):271-4. PubMed ID: 2736307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid metaplasia in aspirates from enlarged spleens: a clue in the absence of peripheral blood findings characteristic of myelofibrosis.
    Sen R; Bhadani PP; Singh H; Sachdeva B; Sen J; Singh S; Gupta M; Mehta K
    Acta Cytol; 2006; 50(4):379-83. PubMed ID: 16900998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha-2 in the treatment of idiopathic myelofibrosis.
    Seewann HL; Gastl G; Lang A; Abbrederis K; Thaler J; Flener R; Huber C
    Blut; 1988 Apr; 56(4):161-3. PubMed ID: 3355903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
    Elliott MA; Tefferi A
    Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis of spleen mediated phenomena in chronic myeloid leukaemia and agnogenic myeloid metaplasia: a non-abscopal mechanism.
    Adler SS
    Scand J Haematol; 1976 Sep; 17(3):153-9. PubMed ID: 788139
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis.
    Manoharan A; Pitney WR
    Scand J Haematol; 1984 Nov; 33(5):453-9. PubMed ID: 6515328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Interferon in myelofibrosis: a case report.
    Dalla KP; Zeigler ZR; Shadduck RK
    Br J Haematol; 1994 Mar; 86(3):654-6. PubMed ID: 8043450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of alpha-interferon in essential thrombocythaemia, polycythaemia vera and myelofibrosis with myeloid metaplasia (MMM): a concise update.
    Sacchi S
    Leuk Lymphoma; 1995 Sep; 19(1-2):13-20. PubMed ID: 8574158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
    Mesa RA; Li CY; Schroeder G; Tefferi A
    Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelofibrosis presenting as splenic tumor.
    Macumber C; Phan TG; Young GA; Selby WS
    Dig Dis Sci; 1999 Sep; 44(9):1817-22. PubMed ID: 10505720
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute myelofibrosis: response to recombinant human interferon alpha-2a.
    List AF; Kummet TD; Kerr DM
    Leuk Res; 1990; 14(4):321-6. PubMed ID: 2332985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
    Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
    Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agnogenic myeloid metaplasia in childhood: a report of two cases and efficiency of intravenous high dose methylprednisolone treatment.
    Cetingül N; Yener E; Oztop S; Nisli G; Soydan S
    Acta Paediatr Jpn; 1994 Dec; 36(6):697-700. PubMed ID: 7871986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelosclerosis in agnogenic myeloid metaplasia.
    Feldman F
    Semin Roentgenol; 1974 Jul; 9(3):195-207. PubMed ID: 4601848
    [No Abstract]   [Full Text] [Related]  

  • 20. [Essential thrombocythemia transformed to myelofibrosis with myeloid metaplasia after seven years].
    Yamagishi M; Yamamoto T; Ohmori M
    Rinsho Ketsueki; 1991 Mar; 32(3):239-43. PubMed ID: 2041165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.